Galectin Therapeutics Inc. (SWB:PHPN) Financings

Galectin Therapeutics Inc.

Financings

RaiseDate
Unsecured, convertible line of credit
Announced: convertible
Buyers: Richard E. Uihlein (Chairman; provides a new $10 million unsecured, convertible line of credit)
Insiders: Line of credit provided by the company's chairman, Richard E. Uihlein
Use of proceeds: Together with cash, to fund currently expected expenditures through at least March 2027
Dec 19, 2025
Convertible promissory notes under an unsecured line of credit, with stock purchase warrants
Announced: up to 200,000 stock purchase warrants (20,000 per $1 million of borrowings), exercise…
Buyers: Richard E. Uihlein (Provides the new $10 million unsecured convertible line of credit)
Insiders: The credit line is provided by Richard E. Uihlein, Chairman of the Board and largest individual stockholder
Use of proceeds: To cover projected expenditures through June 2026
Jul 9, 2025

Read by 6ix AI from the company's releases